2026 Global Colorectal Cancer Congress to Advance Precision Medicine and Health Equity

The Global Colon Cancer Association announced it will host the 2026 Global Colorectal Cancer Congress on November 5–6 in a hybrid format, with virtual participation open worldwide and in-person activities stationed in Nairobi, Kenya.

Key Clinical Takeaways:

• The two-day hybrid event brings together international advocates, healthcare professionals, researchers, and policymakers to tackle disparities in colorectal cancer care.
• Free virtual attendance is accessible across more than 60 languages without requiring organizational membership.
• Sponsors supporting the 2026 initiative include Bristol Myers Squibb, Guardant Health, and Johnson & Johnson.

Congress Agenda and Nairobi Opening Sessions

Under the theme “Together We Shape the Road Ahead for CRC,” the gathering opens with remarks from GCCA CEO Andrew Spiegel and President Nicole Sheahan. Dr. Joan-Paula Bor-Malenya, Head of Kenya’s National Cancer Control Program, will follow with an evaluation of the domestic state of colorectal cancer. Nicole Sheahan stated that access to information, early detection, appropriate treatment, and supportive care remains unequal globally, making international collaboration essential for standardizing patient outcomes.

Day one focuses on prevention, diagnostics, and health equity. Dr. Partha Basu of the International Agency for Research on Cancer delivers the opening keynote on risk reduction and screening strategies. Helena Harnik of The Synergist leads a subsequent panel on biomarker testing and precision medicine applications. Dr. Apeksha Patel of Novartis chairs a dedicated session examining artificial intelligence models within diagnostic pathways and patient management.

Health Equity Sessions and Evening Leadership Awards

Afternoon discussions pivot toward grassroots healthcare delivery under the heading of advancing health equity through local solutions. Three dedicated panels analyze community screening frameworks, ostomy support systems, and the structural expansion of health system capacity via specialized training programs and policy advocacy. The first day concludes with an in-person Blue Dinner in Nairobi, hosting the presentation of the Global CRC Leadership Awards to honor achievements in policy, community engagement, and emerging global advocacy.

The second day centers on caregiver experiences and survivorship frameworks. The association will officially introduce its new Global Ostomy Program, designed to eliminate financial barriers preventing patients from acquiring essential ostomy supplies. Dr. Mazvita Muchengeti, Head of the South African National Cancer Registry at the National Institute for Communicable Diseases, leads a policy-focused session connecting registry data directly to patient access initiatives.

Virtual Access Remains Free via Sponsored Portal

Virtual participation remains free for attendees joining the live broadcasts on November 5 and the morning of November 6, East Africa Time, via the official registration portal at gccacongress.org. The platform features simultaneous translation across more than 60 languages alongside on-demand access to session recordings. Bristol Myers Squibb, Guardant Health, and Johnson & Johnson underwrite the congress costs.

Following the virtual broadcasts, in-person participants in Nairobi will assemble patient care kits for Kenyatta National Hospital, review resources at the GCCA Membership Hub, and outline operational targets for the upcoming March 2027 colorectal cancer awareness initiative.

More on this story: Researchers report distinct biological features in early-onset colorectal cancer · ESMO 2026: Apalutamide Reduces Metastasis Risk by 51% in Prostate Cancer

More on Colorectal Cancer: Ultra-Processed Foods and Colorectal Cancer: New Study Challenges Broad Assumptions